{"podcast":{"title":"The Doctor's Lounge","slug":"the-doctor-s-lounge-7442524","podcast_index_feed_id":7442524,"rss_url":"https://api.riverside.fm/hosting/5aWyTD7j.rss","website_url":"https://thedoctorslounge.buzzsprout.com","image_url":"https://hosting-media.riverside.com/media/podcasts/59501f59-aca4-4def-bd99-a043a6802263/logos/147cc477-82c6-40d3-8a78-59fd96e7eb31.png","author":"The Doctor's Lounge","episode_count":64,"summary":"Where scalpels meet systems — and physicians say what they really think. Co-hosted by Anish Koka, MD & Anthony DiGiorgio, DO. Candid talks on healthcare policy, reform, physician autonomy & patient care.","last_synced_at":"2026-06-21T14:17:24.601594+00:00","page_url":"https://stenobird.com/podcast/the-doctor-s-lounge-7442524"},"episode":{"title":"From Tehran to the C-Suite: Biotech CEO Ali Mortazavi on AI, Drug Discovery, and the Me-Too Problem","slug":"from-tehran-to-the-c-suite-biotech-ceo-ali-mortazavi-on-ai-drug-discovery-and-the-me-too-problem","published_at":"2026-04-03T01:00:00+00:00","page_url":"https://stenobird.com/podcast/the-doctor-s-lounge-7442524/from-tehran-to-the-c-suite-biotech-ceo-ali-mortazavi-on-ai-drug-discovery-and-the-me-too-problem","show_page_url":"https://stenobird.com/podcast/the-doctor-s-lounge-7442524","url":"https://api.riverside.com/hosting-analytics/media/e3e976392df8e0c8a30078600b9c1d5e2ac8f342163031dd50d9bd06891e7df2/eyJlcGlzb2RlSWQiOiI0YjY4YWE4Ny1jY2ZiLTQzNzItOWNiNC02YWQwOWFmZGUwNjciLCJwb2RjYXN0SWQiOiI1OTUwMWY1OS1hY2E0LTRkZWYtYmQ5OS1hMDQzYTY4MDIyNjMiLCJhY2NvdW50SWQiOiI2OTJmNTE0YTZlYjA1ZDMyNzdmZTA2OWQiLCJwYXRoIjoibWVkaWEvY2xpcHMvNjlhMzdhM2EyNjNmYThhYWRiMmY4Y2Q2L2RvY3RvcnMtbG91bmdlcy1zdHVkaW8tY29tcG9zZXItMjAyNi0zLTFfXzAtMjgtNTgubXAzIn0=.mp3","audio_url":"https://api.riverside.com/hosting-analytics/media/e3e976392df8e0c8a30078600b9c1d5e2ac8f342163031dd50d9bd06891e7df2/eyJlcGlzb2RlSWQiOiI0YjY4YWE4Ny1jY2ZiLTQzNzItOWNiNC02YWQwOWFmZGUwNjciLCJwb2RjYXN0SWQiOiI1OTUwMWY1OS1hY2E0LTRkZWYtYmQ5OS1hMDQzYTY4MDIyNjMiLCJhY2NvdW50SWQiOiI2OTJmNTE0YTZlYjA1ZDMyNzdmZTA2OWQiLCJwYXRoIjoibWVkaWEvY2xpcHMvNjlhMzdhM2EyNjNmYThhYWRiMmY4Y2Q2L2RvY3RvcnMtbG91bmdlcy1zdHVkaW8tY29tcG9zZXItMjAyNi0zLTFfXzAtMjgtNTgubXAzIn0=.mp3","summary":"Guest: Ali Mortazavi | CEO, Tangram Therapeutics (formerly E-Therapeutics), London, UK Episode Summary: Ali Mortazavi is not your typical biotech CEO. A computer scientist by training, former professional chess player, and veteran of financial markets, he invested in an RNAi company in 2012 — and then, by his own admission, made the crazy decision to become its CEO with zero background in biology, chemistry, or medicine. What followed is a 14-year education in the brutal realities of drug development — and a front-row seat to the AI revolution now reshaping it. In this wide-ranging conversation, Mortazavi draws on his extraordinary personal story (fleeing revolutionary Iran as a child, arriving in London unable to speak English, rising through chess and finance) to offer a uniquely cross-disciplinary perspective on why biotech is stuck in a me-too loop, why the incentive system is the real bottleneck, and where AI is — and isn't — changing the game. 0:00 - Introduction & Ali's Background 1:07 - The Iranian Revolution at Nine Years Old 4:44 - Fleeing Iran, Arriving in London 6:38 - The Refugee Experience and Starting Over 7:49 - Computer Science in 1990 9:53 - Becoming a Professional Chess Player 11:06 - The Vishwanathan Anand Moment 13:17 - From Chess to Finance to Biotech CEO 14:44 - The Gleevec Illusion and the Reality of Drug Development 16:07 - Jay Bhattacharya, Reproducibility, and the PubMed Button 18:18 - LLMs as Scientific Compression Systems 20:15 - Why LLMs Give \"The Average Answer\" — The Co-Pilot Model 23:44 - Vibe Coding and the Explosion of Code 25:36 - AI Won't Replace 10x Coders — It Will Replace 90 of 100 26:16 - The GalNAC Case Study: 35 Years of Forgotten Innovation 31:10 - The Me-Too Algorithm and Biotech VC Incentives 34:40 - GLP-1s: Another 30…","meta_description":"Guest: Ali Mortazavi | CEO, Tangram Therapeutics (formerly E-Therapeutics), London, UK Episode Summary: Ali Mortazavi is not your typical biotech CEO. A c…","key_points":[],"chapters":[],"topics":[],"duration_seconds":3546,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/the-doctor-s-lounge-7442524/episodes/from-tehran-to-the-c-suite-biotech-ceo-ali-mortazavi-on-ai-drug-discovery-and-the-me-too-problem/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/the-doctor-s-lounge-7442524/from-tehran-to-the-c-suite-biotech-ceo-ali-mortazavi-on-ai-drug-discovery-and-the-me-too-problem.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]}}